ALBUTEROL

ALBUTEROL was reported 299876 times

ALBUTEROL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 233 0.6021
1 SPIROMETRY ABNORMAL 287 0.4799
2 CONGENITAL HIATUS HERNIA 106 0.4649
3 TOTAL LUNG CAPACITY ABNORMAL 174 0.4473
4 PULMONARY VASCULITIS 231 0.4294
5 TOTAL LUNG CAPACITY INCREASED 115 0.4228
6 MITE ALLERGY 270 0.4122
7 ANALGESIC THERAPY 116 0.3614
8 DRUG THERAPY 118 0.3481
9 REVERSIBLE AIRWAYS OBSTRUCTION 172 0.3386
10 MYCOTIC ALLERGY 274 0.3205
11 DUST ALLERGY 312 0.3180
12 EJECTION FRACTION 178 0.3064
13 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 159 0.3040
14 SENSITISATION 224 0.2951
15 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 268 0.2891
16 BRONCHIAL WALL THICKENING 178 0.2476
17 BRONCHIAL SECRETION RETENTION 289 0.2268
18 MULTIPLE DRUG THERAPY 171 0.2268
19 PULMONARY FUNCTION TEST ABNORMAL 325 0.2085
20 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 152 0.2074
21 CONJUNCTIVITIS ALLERGIC 302 0.2038
22 FULL BLOOD COUNT ABNORMAL 2104 0.1987
23 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 342 0.1676
24 POLYCYSTIC OVARIES 256 0.1649
25 RHINITIS ALLERGIC 709 0.1591
26 INHALATION THERAPY 99 0.1571
27 NEURITIS 240 0.1553
28 OBSTRUCTIVE AIRWAYS DISORDER 1709 0.1535
29 TEMPERATURE REGULATION DISORDER 332 0.1489
30 RESPIRATORY SYMPTOM 411 0.1444
31 TOTAL LUNG CAPACITY DECREASED 211 0.1320
32 LUPUS VULGARIS 161 0.1278
33 FORCED EXPIRATORY VOLUME DECREASED 352 0.1241
34 INCREASED BRONCHIAL SECRETION 316 0.1234
35 CHEST X-RAY ABNORMAL 378 0.1232
36 SPUTUM CULTURE POSITIVE 99 0.1219
37 OBSTRUCTIVE SLEEP APNOEA SYNDROME 176 0.1206
38 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2049 0.1205
39 SEDATION COMPLICATION 304 0.1190
40 BREATH SOUNDS ABNORMAL 586 0.1187
41 DEVICE DELIVERY SYSTEM ISSUE 3248 0.1185
42 NASAL POLYPS 584 0.1185
43 X-RAY ABNORMAL 209 0.1168
44 BRONCHIECTASIS 770 0.1142
45 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 232 0.1119
46 BRONCHIAL HYPERREACTIVITY 115 0.0956
47 NORMOCHROMIC NORMOCYTIC ANAEMIA 285 0.0948
48 DEEP VEIN THROMBOSIS POSTOPERATIVE 188 0.0939
49 WHEEZING 5568 0.0938
50 SPUTUM INCREASED 196 0.0905
51 BLOOD IMMUNOGLOBULIN E INCREASED 219 0.0903
52 PORPHYRIA ACUTE 129 0.0899
53 RHONCHI 123 0.0890
54 LUNG OPACITY 231 0.0876
55 ASTHMA 9847 0.0870
56 CREATININE RENAL CLEARANCE DECREASED 322 0.0804
57 ASTHMATIC CRISIS 293 0.0801
58 DISLOCATION OF VERTEBRA 180 0.0788
59 RETINITIS 136 0.0787
60 CHRONIC SINUSITIS 290 0.0772
61 SPUTUM DISCOLOURED 702 0.0739
62 BLOOD PHOSPHORUS INCREASED 201 0.0735
63 NASAL OBSTRUCTION 138 0.0735
64 HYPERPHOSPHATAEMIA 158 0.0734
65 RALES 426 0.0733
66 NEPHROGENIC ANAEMIA 335 0.0722
67 PLEURITIC PAIN 193 0.0699
68 HYPERPARATHYROIDISM SECONDARY 174 0.0694
69 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3615 0.0692
70 EAR PRURITUS 240 0.0684
71 FOOD ALLERGY 526 0.0681
72 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 362 0.0664
73 UPPER-AIRWAY COUGH SYNDROME 545 0.0661
74 PULMONARY FUNCTION TEST DECREASED 276 0.0630
75 FOETAL DEATH 324 0.0624
76 EOSINOPHIL COUNT INCREASED 488 0.0585
77 PRODUCTIVE COUGH 2733 0.0572
78 DIASTOLIC DYSFUNCTION 173 0.0560
79 BONE EROSION 197 0.0556
80 PRODUCT CLEANING INADEQUATE 145 0.0543
81 OESOPHAGEAL SPASM 100 0.0542
82 ARTERIOSCLEROSIS CORONARY ARTERY 357 0.0538
83 REBOUND ACID HYPERSECRETION 162 0.0535
84 BURSITIS 649 0.0534
85 EMPHYSEMA 523 0.0518
86 CYSTIC FIBROSIS 287 0.0518
87 BLOOD LACTIC ACID INCREASED 265 0.0503
88 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2406 0.0500
89 FACET JOINT SYNDROME 163 0.0500
90 CANDIDIASIS 200 0.0498
91 SWOLLEN JOINT COUNT INCREASED 159 0.0498
92 ATELECTASIS 480 0.0496
93 LUNG CONSOLIDATION 138 0.0493
94 PULMONARY CONGESTION 644 0.0488
95 BENIGN PROSTATIC HYPERPLASIA 251 0.0486
96 SINUS PAIN 113 0.0484
97 SLEEP APNOEA SYNDROME 920 0.0482
98 VASCULITIS 557 0.0478
99 BRAIN NATRIURETIC PEPTIDE INCREASED 146 0.0473
100 CHOLECYSTITIS CHRONIC 316 0.0472
101 HYPERCAPNIA 139 0.0461
102 EOSINOPHIL COUNT DECREASED 109 0.0457
103 MULTIPLE ALLERGIES 357 0.0455
104 PULMONARY ALVEOLAR HAEMORRHAGE 254 0.0452
105 INTENTIONAL DEVICE MISUSE 199 0.0451
106 IRON DEFICIENCY 201 0.0446
107 INCREASED UPPER AIRWAY SECRETION 229 0.0446
108 AORTIC STENOSIS 153 0.0439
109 PULMONARY FIBROSIS 835 0.0435
110 NEUROLOGICAL SYMPTOM 248 0.0433
111 DYSPNOEA EXERTIONAL 1620 0.0430
112 ARTERIOSCLEROSIS 403 0.0428
113 DRUG TOLERANCE DECREASED 120 0.0427
114 OBSTRUCTION 170 0.0425
115 C-REACTIVE PROTEIN ABNORMAL 270 0.0420
116 HAEMOPTYSIS 1172 0.0420
117 RHINOVIRUS INFECTION 160 0.0411
118 MATERNAL EXPOSURE TIMING UNSPECIFIED 152 0.0404
119 PERIPHERAL VENOUS DISEASE 165 0.0404
120 HYPERCHOLESTEROLAEMIA 390 0.0404
121 RHEUMATIC FEVER 180 0.0403
122 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 262 0.0403
123 THROAT CLEARING 151 0.0402
124 BRONCHOSPASM 570 0.0399
125 IMMUNODEFICIENCY 587 0.0393
126 ORTHOPNOEA 124 0.0389
127 BLOOD TEST ABNORMAL 547 0.0389
128 RESPIRATION ABNORMAL 268 0.0388
129 SECRETION DISCHARGE 477 0.0380
130 PHARMACEUTICAL PRODUCT COMPLAINT 985 0.0379
131 OBESITY 596 0.0374
132 PULMONARY MASS 556 0.0373
133 HYPOXIA 1306 0.0370
134 OXYGEN SATURATION ABNORMAL 105 0.0370
135 BLOOD CALCIUM DECREASED 414 0.0368
136 DEVICE MECHANICAL ISSUE 500 0.0364
137 UPPER RESPIRATORY TRACT INFECTION 1653 0.0357
138 SLEEP TERROR 150 0.0356
139 RHEUMATOID FACTOR POSITIVE 205 0.0355
140 CARDIAC MURMUR 307 0.0354
141 SARCOIDOSIS 168 0.0353
142 END STAGE RENAL DISEASE 643 0.0352
143 EXOSTOSIS 319 0.0349
144 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2465 0.0346
145 TRICUSPID VALVE INCOMPETENCE 271 0.0341
146 PRESCRIBED OVERDOSE 657 0.0339
147 JAUNDICE CHOLESTATIC 119 0.0337
148 DUODENAL ULCER PERFORATION 250 0.0336
149 BREAST CANCER STAGE III 216 0.0333
150 COELIAC DISEASE 327 0.0333
151 RESPIRATORY ACIDOSIS 129 0.0328
152 HYPERLIPIDAEMIA 392 0.0328
153 BLOOD URIC ACID INCREASED 188 0.0325
154 EOSINOPHILIA 568 0.0324
155 ACUTE RESPIRATORY FAILURE 622 0.0323
156 FIBROMYALGIA 786 0.0323
157 APPENDICITIS 300 0.0321
158 RESPIRATORY DISORDER 960 0.0321
159 CHEST DISCOMFORT 3265 0.0319
160 PHARYNGOLARYNGEAL PAIN 169 0.0318
161 BRONCHITIS 2336 0.0315
162 LUNG DISORDER 1539 0.0314
163 FOLLICULITIS 325 0.0310
164 DYSPHONIA 1812 0.0310
165 RESPIRATORY TRACT INFECTION 802 0.0308
166 RHINITIS 248 0.0307
167 NODULE 399 0.0305
168 HYPOPHOSPHATAEMIA 225 0.0304
169 DRUG DOSE OMISSION BY DEVICE 2372 0.0303
170 DYSPNOEA 16950 0.0299
171 INTERVERTEBRAL DISC DEGENERATION 277 0.0299
172 ORTHOSTATIC HYPOTENSION 520 0.0298
173 LYMPHOEDEMA 204 0.0295
174 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 210 0.0293
175 BRONCHIOLITIS 103 0.0292
176 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 148 0.0292
177 CARDIOMEGALY 359 0.0292
178 LOWER RESPIRATORY TRACT INFECTION 1325 0.0291
179 ASPIRATION 319 0.0291
180 GRIP STRENGTH DECREASED 256 0.0291
181 GASTROOESOPHAGEAL REFLUX DISEASE 2339 0.0290
182 LUNG NEOPLASM 124 0.0290
183 HAEMORRHAGIC ANAEMIA 127 0.0289
184 MUSCLE INJURY 239 0.0288
185 VENTRICULAR FIBRILLATION 317 0.0285
186 EXERCISE TOLERANCE DECREASED 164 0.0285
187 DIABETIC NEUROPATHY 141 0.0285
188 OESOPHAGEAL PAIN 112 0.0283
189 SPINAL OSTEOARTHRITIS 249 0.0283
190 AUTOIMMUNE DISORDER 276 0.0283
191 HYPOMANIA 104 0.0283
192 LEFT VENTRICULAR HYPERTROPHY 121 0.0282
193 SCOLIOSIS 175 0.0282
194 PARANASAL SINUS DISCOMFORT 106 0.0280
195 COUGH 7831 0.0279
196 RESPIRATORY TRACT CONGESTION 443 0.0279
197 IMPAIRED QUALITY OF LIFE 397 0.0276
198 EAR PAIN 535 0.0275
199 HIATUS HERNIA 349 0.0269
200 RESPIRATORY DISTRESS 743 0.0269
201 BLOOD CALCIUM INCREASED 236 0.0269
202 ATRIOVENTRICULAR BLOCK FIRST DEGREE 116 0.0267
203 LUNG INFILTRATION 236 0.0267
204 MITRAL VALVE INCOMPETENCE 300 0.0265
205 OXYGEN SATURATION DECREASED 1488 0.0265
206 CARPAL TUNNEL SYNDROME 369 0.0263
207 HYPERVENTILATION 151 0.0260
208 MYASTHENIA GRAVIS 209 0.0259
209 HYPOTHYROIDISM 826 0.0258
210 TROPONIN INCREASED 196 0.0257
211 SEASONAL ALLERGY 362 0.0256
212 WOUND INFECTION 279 0.0255
213 NASAL CONGESTION 1489 0.0253
214 ORAL CANDIDIASIS 329 0.0250
215 SINUS DISORDER 493 0.0249
216 APHONIA 346 0.0248
217 CHRONIC KIDNEY DISEASE 1881 0.0247
218 RENAL FAILURE CHRONIC 190 0.0247
219 MIDDLE INSOMNIA 461 0.0247
220 INCORRECT DOSE ADMINISTERED BY DEVICE 647 0.0247
221 RESPIRATORY RATE INCREASED 218 0.0245
222 PSEUDOMONAS INFECTION 208 0.0242
223 CORONARY ARTERY DISEASE 729 0.0240
224 INFUSION SITE SWELLING 151 0.0240
225 PERIPHERAL VASCULAR DISORDER 123 0.0239
226 DYSLIPIDAEMIA 121 0.0238
227 TYPE 2 DIABETES MELLITUS 802 0.0238
228 DIVERTICULUM 168 0.0236
229 ECONOMIC PROBLEM 357 0.0235
230 WALKING AID USER 155 0.0235
231 ENDOMETRIOSIS 112 0.0235
232 RENAL CYST 185 0.0233
233 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 396 0.0231
234 RESPIRATORY SYNCYTIAL VIRUS INFECTION 201 0.0231
235 POST-TRAUMATIC STRESS DISORDER 154 0.0230
236 PRODUCT DELIVERY MECHANISM ISSUE 123 0.0229
237 PNEUMONIA 7403 0.0228
238 LIVE BIRTH 191 0.0228
239 LIP DRY 206 0.0227
240 CARDIOGENIC SHOCK 324 0.0226
241 PULMONARY HYPERTENSION 470 0.0225
242 SUPRAVENTRICULAR TACHYCARDIA 215 0.0224
243 HELICOBACTER INFECTION 230 0.0224
244 SNEEZING 495 0.0220
245 PNEUMOTHORAX 348 0.0219
246 SINUSITIS 2247 0.0219
247 SINUS TACHYCARDIA 311 0.0219
248 IMPAIRED GASTRIC EMPTYING 298 0.0218
249 GOUT 392 0.0218
250 JOINT RANGE OF MOTION DECREASED 292 0.0218
251 SWOLLEN TONGUE 678 0.0217
252 ABDOMINAL HERNIA 99 0.0217
253 SINUS CONGESTION 293 0.0217
254 POLYP 140 0.0214
255 OSTEOPOROSIS 875 0.0213
256 PLATELET COUNT INCREASED 273 0.0209
257 BLOOD POTASSIUM DECREASED 627 0.0208
258 HYPOVOLAEMIA 122 0.0208
259 BACTERIAL INFECTION 388 0.0208
260 CHOKING SENSATION 114 0.0207
261 RHINORRHOEA 1319 0.0204
262 FLANK PAIN 191 0.0204
263 IRON DEFICIENCY ANAEMIA 187 0.0202
264 LUNG INFECTION 314 0.0202
265 MULTIPLE INJURIES 127 0.0201
266 PULMONARY EMBOLISM 1910 0.0201
267 MYOCARDIAL ISCHAEMIA 228 0.0200
268 FLUID RETENTION 1016 0.0200
269 LUPUS-LIKE SYNDROME 181 0.0199
270 ECCHYMOSIS 136 0.0198
271 RESPIRATORY FAILURE 1445 0.0198
272 PNEUMONIA BACTERIAL 181 0.0197
273 LOWER GASTROINTESTINAL HAEMORRHAGE 145 0.0196
274 CARDIAC FAILURE CONGESTIVE 1564 0.0195
275 ATRIAL FLUTTER 155 0.0194
276 GLUCOSE TOLERANCE IMPAIRED 114 0.0193
277 TACHYPNOEA 262 0.0193
278 JOINT DISLOCATION 203 0.0192
279 SENSITIVITY TO WEATHER CHANGE 101 0.0192
280 CONTRAINDICATED PRODUCT ADMINISTERED 573 0.0189
281 VENTRICULAR EXTRASYSTOLES 196 0.0189
282 ELECTROCARDIOGRAM ABNORMAL 148 0.0188
283 CANDIDA INFECTION 317 0.0188
284 CHOLELITHIASIS 614 0.0187
285 PHARYNGEAL SWELLING 182 0.0186
286 INJURY 1307 0.0186
287 SEDATION 486 0.0185
288 CHEST PAIN 3416 0.0184
289 EAR INFECTION 490 0.0184
290 LEFT VENTRICULAR DYSFUNCTION 123 0.0183
291 SLEEP DISORDER 1293 0.0183
292 HYPOMAGNESAEMIA 255 0.0183
293 SCIATICA 291 0.0182
294 BLOOD CHOLESTEROL INCREASED 848 0.0182
295 IRRITABLE BOWEL SYNDROME 390 0.0182
296 CHOLECYSTITIS ACUTE 103 0.0182
297 SENSATION OF FOREIGN BODY 153 0.0181
298 OSTEOARTHRITIS 768 0.0181
299 OEDEMA PERIPHERAL 2201 0.0180
300 COVID-19 PNEUMONIA 211 0.0179
301 TENDERNESS 186 0.0178
302 UPPER GASTROINTESTINAL HAEMORRHAGE 300 0.0178
303 NIGHT SWEATS 570 0.0177
304 MICTURITION URGENCY 202 0.0177
305 FOOT DEFORMITY 196 0.0177
306 HYPOKALAEMIA 811 0.0176
307 RIB FRACTURE 361 0.0175
308 RESPIRATORY DEPRESSION 214 0.0174
309 MUSCULOSKELETAL CHEST PAIN 270 0.0174
310 RENAL INJURY 512 0.0172
311 ATRIAL FIBRILLATION 1675 0.0172
312 THROAT IRRITATION 766 0.0171
313 GLOSSODYNIA 381 0.0170
314 CHOKING 332 0.0170
315 PERICARDITIS 285 0.0169
316 MENTAL STATUS CHANGES 470 0.0169
317 MAJOR DEPRESSION 123 0.0168
318 TOOTH ABSCESS 171 0.0168
319 CARDIOMYOPATHY 248 0.0168
320 MUSCLE SPASTICITY 206 0.0167
321 JOINT INJURY 358 0.0167
322 PLEURAL EFFUSION 1019 0.0167
323 INTERVERTEBRAL DISC PROTRUSION 365 0.0167
324 DRY MOUTH 1350 0.0166
325 HYPERTENSION 3514 0.0166
326 BODY TEMPERATURE INCREASED 337 0.0165
327 PLEURISY 98 0.0165
328 OSTEOPENIA 250 0.0165
329 GALLBLADDER DISORDER 294 0.0165
330 HAND DEFORMITY 216 0.0165
331 RENAL TUBULAR NECROSIS 161 0.0164
332 NEPHROPATHY 153 0.0164
333 MOBILITY DECREASED 1176 0.0164
334 ATRIAL SEPTAL DEFECT 137 0.0163
335 RED BLOOD CELL SEDIMENTATION RATE INCREASED 181 0.0163
336 BLOOD MAGNESIUM DECREASED 141 0.0163
337 APPETITE DISORDER 108 0.0163
338 HYPONATRAEMIA 916 0.0162
339 DRY THROAT 165 0.0162
340 SKIN LACERATION 176 0.0162
341 DEVICE MALFUNCTION 1135 0.0161
342 HEPATIC ENZYME INCREASED 1100 0.0161
343 BLOOD ALBUMIN DECREASED 128 0.0161
344 ANHEDONIA 424 0.0161
345 VENTRICULAR TACHYCARDIA 266 0.0161
346 ASCITES 473 0.0161
347 DEEP VEIN THROMBOSIS 1045 0.0161
348 OBSESSIVE-COMPULSIVE DISORDER 129 0.0161
349 WEIGHT FLUCTUATION 168 0.0160
350 BLOOD PRESSURE SYSTOLIC INCREASED 312 0.0160
351 BODY HEIGHT DECREASED 171 0.0160
352 VIRAL INFECTION 531 0.0159
353 HEART RATE INCREASED 1575 0.0159
354 ANAPHYLACTIC REACTION 874 0.0158
355 DIABETES MELLITUS INADEQUATE CONTROL 280 0.0158
356 CLOSTRIDIUM DIFFICILE COLITIS 167 0.0157
357 FEELING JITTERY 300 0.0157
358 RIGHT VENTRICULAR FAILURE 110 0.0157
359 INITIAL INSOMNIA 161 0.0157
360 VITAMIN D DEFICIENCY 153 0.0157
361 ANXIETY 4454 0.0156
362 DEPRESSED LEVEL OF CONSCIOUSNESS 617 0.0156
363 CYANOSIS 245 0.0156
364 MALNUTRITION 174 0.0155
365 BLOOD IRON DECREASED 184 0.0155
366 NEURALGIA 377 0.0155
367 DRUG INTOLERANCE 1496 0.0155
368 INTENTIONAL PRODUCT MISUSE 1350 0.0154
369 EXPOSURE DURING PREGNANCY 955 0.0153
370 PNEUMONITIS 418 0.0153
371 THROAT TIGHTNESS 415 0.0153
372 OROPHARYNGEAL PAIN 1419 0.0153
373 ELECTROLYTE IMBALANCE 178 0.0153
374 BLOOD PRESSURE DIASTOLIC DECREASED 113 0.0153
375 RETCHING 326 0.0153
376 COGNITIVE DISORDER 714 0.0153
377 HYPERGLYCAEMIA 557 0.0153
378 INFUSION RELATED REACTION 1009 0.0152
379 DIABETES MELLITUS 1160 0.0152
380 VITAMIN D DECREASED 130 0.0152
381 LACRIMATION INCREASED 458 0.0151
382 DECREASED ACTIVITY 163 0.0151
383 TRANSIENT ISCHAEMIC ATTACK 509 0.0151
384 BIPOLAR DISORDER 164 0.0151
385 PHARYNGITIS 187 0.0151
386 INFUSION SITE ERYTHEMA 127 0.0150
387 HEPATIC CIRRHOSIS 283 0.0150
388 SWELLING FACE 974 0.0149
389 APNOEA 116 0.0149
390 ACUTE KIDNEY INJURY 2270 0.0148
391 PULMONARY OEDEMA 661 0.0147
392 INSURANCE ISSUE 225 0.0147
393 NEUTROPENIC SEPSIS 105 0.0147
394 PULMONARY HAEMORRHAGE 115 0.0147
395 LEUKOCYTOSIS 266 0.0147
396 LOWER LIMB FRACTURE 282 0.0147
397 PARKINSONISM 143 0.0147
398 PRODUCT QUALITY ISSUE 1977 0.0145
399 RENAL FAILURE 1928 0.0145
400 COAGULOPATHY 241 0.0144
401 DEPRESSION 3283 0.0144
402 ROTATOR CUFF SYNDROME 185 0.0144
403 RENAL FAILURE ACUTE 611 0.0144
404 MIGRAINE 1372 0.0144
405 FLUID OVERLOAD 209 0.0143
406 ADRENAL INSUFFICIENCY 174 0.0143
407 HAEMATOCRIT DECREASED 284 0.0143
408 DENTAL CARIES 158 0.0143
409 OEDEMA 774 0.0143
410 RASH ERYTHEMATOUS 681 0.0142
411 DYSURIA 524 0.0142
412 BODY TEMPERATURE DECREASED 140 0.0142
413 BLOOD UREA INCREASED 238 0.0142
414 CONSTIPATION 3098 0.0142
415 LIP SWELLING 473 0.0142
416 CHOLECYSTITIS 169 0.0142
417 LIVER FUNCTION TEST INCREASED 304 0.0141
418 FACIAL PAIN 126 0.0141
419 CELLULITIS 711 0.0141
420 TACHYCARDIA 1249 0.0140
421 HYPERSENSITIVITY 2608 0.0140
422 RESTLESS LEGS SYNDROME 254 0.0140
423 PEMPHIGUS 174 0.0139
424 INFLUENZA 1550 0.0139
425 HEART RATE IRREGULAR 314 0.0139
426 CONTUSION 1337 0.0139
427 ANGIOEDEMA 614 0.0139
428 WHITE BLOOD CELL COUNT INCREASED 532 0.0139
429 PARAESTHESIA ORAL 200 0.0139
430 LIGAMENT SPRAIN 137 0.0138
431 RECTAL HAEMORRHAGE 595 0.0138
432 CHOLECYSTECTOMY 158 0.0138
433 HYPERKALAEMIA 485 0.0138
434 IMPAIRED HEALING 454 0.0138
435 ORAL DISORDER 101 0.0138
436 OROPHARYNGEAL DISCOMFORT 124 0.0137
437 BRAIN FOG 215 0.0137
438 EJECTION FRACTION DECREASED 213 0.0137
439 PERICARDIAL EFFUSION 315 0.0136
440 JOINT SWELLING 1643 0.0136
441 EYE PRURITUS 457 0.0136
442 SMALL INTESTINAL OBSTRUCTION 167 0.0136
443 CONCUSSION 105 0.0135
444 PANIC ATTACK 494 0.0135
445 BACK INJURY 147 0.0135
446 CYSTITIS 430 0.0135
447 INTERNATIONAL NORMALISED RATIO INCREASED 385 0.0135
448 PRODUCT COMPLAINT 341 0.0134
449 OESOPHAGITIS 147 0.0134
450 CONGENITAL ANOMALY 104 0.0134
451 LACTIC ACIDOSIS 435 0.0134
452 MULTIPLE ORGAN DYSFUNCTION SYNDROME 380 0.0134
453 GASTROENTERITIS VIRAL 242 0.0134
454 POOR QUALITY SLEEP 288 0.0134
455 DECUBITUS ULCER 109 0.0134
456 HYPERHIDROSIS 1720 0.0133
457 GASTRITIS 351 0.0133
458 POLYURIA 109 0.0133
459 PNEUMONIA ASPIRATION 331 0.0132
460 THROMBOSIS 1064 0.0132
461 ILLNESS 1354 0.0131
462 ARTHRITIS 1026 0.0130
463 ABDOMINAL PAIN 3033 0.0130
464 URINARY RETENTION 435 0.0130
465 WRIST FRACTURE 156 0.0130
466 AORTIC ANEURYSM 99 0.0130
467 NEUTROPHIL COUNT INCREASED 133 0.0130
468 ANKLE FRACTURE 201 0.0130
469 TRANSFUSION 136 0.0130
470 SPINAL COMPRESSION FRACTURE 107 0.0129
471 DELIRIUM 449 0.0129
472 URINE OUTPUT DECREASED 113 0.0129
473 HOSPICE CARE 127 0.0128
474 GENERAL PHYSICAL HEALTH DETERIORATION 1484 0.0128
475 GASTROENTERITIS 187 0.0128
476 ANGINA PECTORIS 367 0.0128
477 BLOOD SODIUM DECREASED 241 0.0128
478 PHARYNGEAL OEDEMA 196 0.0127
479 WOUND 356 0.0127
480 CATARACT 756 0.0127
481 PYELONEPHRITIS 110 0.0127
482 INFUSION SITE PAIN 163 0.0126
483 DISCOMFORT 771 0.0126
484 GLAUCOMA 243 0.0126
485 NASOPHARYNGITIS 2314 0.0125
486 DEVICE FAILURE 191 0.0125
487 TENDONITIS 194 0.0125
488 GROIN PAIN 110 0.0125
489 ILL-DEFINED DISORDER 760 0.0125
490 MUSCLE STRAIN 108 0.0125
491 BACK PAIN 2900 0.0125
492 BLISTER 701 0.0125
493 SWELLING 1165 0.0124
494 BALANCE DISORDER 1072 0.0124
495 INCREASED TENDENCY TO BRUISE 114 0.0124
496 INFECTION 1790 0.0124
497 ABDOMINAL DISTENSION 1290 0.0123
498 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 576 0.0123
499 MUSCULOSKELETAL PAIN 646 0.0123
500 DYSPEPSIA 1211 0.0123
501 AMNESIA 800 0.0123
502 SEPSIS 1369 0.0123
503 STOMATITIS 744 0.0123
504 POOR QUALITY DEVICE USED 123 0.0122
505 FRUSTRATION TOLERANCE DECREASED 99 0.0122
506 ROAD TRAFFIC ACCIDENT 511 0.0122
507 CORONARY ARTERY OCCLUSION 167 0.0122
508 TREMOR 2020 0.0122
509 ORAL PAIN 271 0.0121
510 PALPITATIONS 1417 0.0121
511 CONDITION AGGRAVATED 3677 0.0121
512 HEPATIC STEATOSIS 225 0.0121
513 LIMB INJURY 327 0.0120
514 DECREASED IMMUNE RESPONSIVENESS 118 0.0120
515 BREAST CANCER STAGE II 100 0.0120
516 RENAL DISORDER 560 0.0120
517 STAPHYLOCOCCAL INFECTION 396 0.0120
518 JOINT STIFFNESS 314 0.0120
519 ANOREXIA 154 0.0119
520 URTICARIA 2000 0.0119
521 NECK PAIN 665 0.0119
522 ULCER 189 0.0119
523 HAEMATEMESIS 301 0.0119
524 ILEUS 147 0.0118
525 URINARY INCONTINENCE 350 0.0118
526 MYOPATHY 102 0.0118
527 HYSTERECTOMY 102 0.0118
528 HEART RATE DECREASED 413 0.0117
529 RESPIRATORY ARREST 324 0.0117
530 HYPOTENSION 2357 0.0117
531 ACUTE MYOCARDIAL INFARCTION 344 0.0117
532 AGGRESSION 583 0.0116
533 PULMONARY THROMBOSIS 127 0.0116
534 PERIPHERAL SWELLING 1792 0.0116
535 DEPRESSED MOOD 614 0.0116
536 DEHYDRATION 1549 0.0116
537 DYSPHAGIA 1101 0.0116
538 DEVICE DEFECTIVE 201 0.0116
539 BLADDER DISORDER 115 0.0116
540 MUSCULAR WEAKNESS 1316 0.0116
541 CARDIAC DISORDER 1083 0.0116
542 PHARYNGITIS STREPTOCOCCAL 125 0.0115
543 BLOOD CREATININE INCREASED 752 0.0115
544 GASTROINTESTINAL HAEMORRHAGE 961 0.0115
545 DISABILITY 227 0.0115
546 HAEMATURIA 393 0.0115
547 TUBULOINTERSTITIAL NEPHRITIS 215 0.0115
548 TREATMENT NONCOMPLIANCE 627 0.0114
549 MUSCLE SPASMS 2099 0.0114
550 SCHIZOPHRENIA 139 0.0114
551 PYREXIA 3955 0.0114
552 LYMPHADENOPATHY 404 0.0114
553 FUNGAL INFECTION 380 0.0114
554 MASS 159 0.0114
555 DEVICE OCCLUSION 160 0.0114
556 ABNORMAL DREAMS 313 0.0113
557 BURNING SENSATION 794 0.0113
558 GENERALISED OEDEMA 140 0.0113
559 PRESYNCOPE 275 0.0113
560 CRYING 411 0.0113
561 PSYCHOMOTOR HYPERACTIVITY 187 0.0113
562 PRODUCT TASTE ABNORMAL 152 0.0112
563 POOR VENOUS ACCESS 116 0.0112
564 ABDOMINAL PAIN UPPER 2307 0.0112
565 INSOMNIA 2983 0.0112
566 CYST 139 0.0112
567 UNRESPONSIVE TO STIMULI 289 0.0112
568 LACERATION 105 0.0112
569 ANGER 377 0.0111
570 HYPOAESTHESIA ORAL 168 0.0111
571 NERVOUSNESS 582 0.0111
572 NOCTURIA 135 0.0111
573 HEADACHE 6968 0.0111
574 SCAR 190 0.0111
575 SYNOVITIS 200 0.0111
576 MOTOR DYSFUNCTION 113 0.0111
577 HAEMORRHOIDS 216 0.0111
578 SINUS BRADYCARDIA 107 0.0111
579 UROSEPSIS 102 0.0110
580 BLOOD POTASSIUM INCREASED 179 0.0110
581 PARANOIA 190 0.0110
582 SPLENOMEGALY 129 0.0110
583 BLOOD BILIRUBIN INCREASED 297 0.0110
584 HEPATOMEGALY 108 0.0110
585 MUSCULOSKELETAL DISCOMFORT 189 0.0110
586 FOOT FRACTURE 208 0.0110
587 WEIGHT INCREASED 2455 0.0110
588 EAR DISCOMFORT 112 0.0109
589 WEIGHT DECREASED 3036 0.0109
590 FALL 3616 0.0109
591 INTERNAL HAEMORRHAGE 124 0.0108
592 BONE DISORDER 197 0.0108
593 DIVERTICULITIS 299 0.0108
594 EPISTAXIS 807 0.0108
595 ASTHENIA 4056 0.0108
596 DERMATITIS CONTACT 123 0.0108
597 ABNORMAL BEHAVIOUR 427 0.0108
598 PAIN IN JAW 305 0.0108
599 BLOOD PRESSURE INCREASED 1644 0.0107
600 URINARY TRACT INFECTION 1832 0.0107
601 BLOOD PRESSURE FLUCTUATION 256 0.0107
602 CONFUSIONAL STATE 1723 0.0107
603 LUNG NEOPLASM MALIGNANT 438 0.0106
604 PREGNANCY 213 0.0106
605 ARTHROPATHY 591 0.0106
606 DEVICE USE ISSUE 186 0.0106
607 GASTROINTESTINAL DISORDER 952 0.0106
608 FREQUENT BOWEL MOVEMENTS 285 0.0105
609 PANCREATITIS 555 0.0105
610 HALLUCINATION 791 0.0105
611 VOMITING 4925 0.0105
612 TOOTH INFECTION 138 0.0105
613 POST PROCEDURAL COMPLICATION 201 0.0105
614 SYSTEMIC LUPUS ERYTHEMATOSUS 370 0.0104
615 BLOOD ALKALINE PHOSPHATASE INCREASED 258 0.0104
616 PAIN IN EXTREMITY 3060 0.0104
617 PELVIC PAIN 188 0.0103
618 PRODUCT PRESCRIBING ERROR 246 0.0103
619 LOCAL SWELLING 180 0.0103
620 FEELING HOT 632 0.0103
621 FEELING COLD 287 0.0103
622 CLOSTRIDIUM DIFFICILE INFECTION 225 0.0103
623 BACK DISORDER 167 0.0103
624 HYPOAESTHESIA 1537 0.0103
625 TOOTH FRACTURE 113 0.0102
626 THYROID DISORDER 158 0.0102
627 ANAEMIA 1952 0.0102
628 LETHARGY 588 0.0102
629 MEMORY IMPAIRMENT 1404 0.0102
630 COVID-19 1792 0.0102
631 MEDICATION ERROR 566 0.0102
632 MELAENA 224 0.0102
633 TINNITUS 467 0.0102
634 KIDNEY INFECTION 199 0.0101
635 HIP ARTHROPLASTY 155 0.0101
636 MOOD ALTERED 276 0.0101
637 TASTE DISORDER 205 0.0101
638 PAIN 6189 0.0101
639 SARS-COV-2 TEST POSITIVE 133 0.0101
640 LIVER INJURY 247 0.0101
641 THROMBOCYTOPENIA 1123 0.0100
642 MENTAL DISORDER 436 0.0100
643 TOOTHACHE 181 0.0100
644 PRODUCT DOSE OMISSION IN ERROR 283 0.0100
645 UPPER LIMB FRACTURE 199 0.0100
646 TEMPERATURE INTOLERANCE 103 0.0100
647 MACULAR DEGENERATION 119 0.0100
648 THERAPY INTERRUPTED 712 0.0100
649 METABOLIC ACIDOSIS 318 0.0099
650 NIGHTMARE 344 0.0099
651 HYPOPHAGIA 254 0.0099
652 GAIT DISTURBANCE 1901 0.0099
653 EYE INFECTION 112 0.0099
654 RHEUMATOID ARTHRITIS 1125 0.0099
655 SUICIDAL IDEATION 907 0.0099
656 BLOOD TRIGLYCERIDES INCREASED 175 0.0099
657 OVARIAN CYST 99 0.0099
658 ACTIVITIES OF DAILY LIVING IMPAIRED 196 0.0099
659 DIPLOPIA 257 0.0099
660 HAIR COLOUR CHANGES 123 0.0099
661 HYPERCALCAEMIA 122 0.0099
662 AGITATION 724 0.0098
663 FEAR 265 0.0098
664 GAIT INABILITY 329 0.0098
665 MUSCULOSKELETAL STIFFNESS 860 0.0098
666 COLD SWEAT 173 0.0098
667 HAEMATOMA 254 0.0098
668 CHILLS 1149 0.0098
669 PULMONARY ARTERIAL HYPERTENSION 142 0.0098
670 SYNCOPE 979 0.0098
671 PARAESTHESIA 1539 0.0098
672 BACTERAEMIA 116 0.0098
673 NEPHROLITHIASIS 448 0.0098
674 QUALITY OF LIFE DECREASED 131 0.0098
675 CONJUNCTIVITIS 181 0.0097
676 HYPOGLYCAEMIA 473 0.0097
677 HAEMOGLOBIN DECREASED 1001 0.0097
678 FAECES DISCOLOURED 211 0.0097
679 OSTEOMYELITIS 176 0.0097
680 TRANSAMINASES INCREASED 216 0.0097
681 DIZZINESS 4845 0.0097
682 MUSCLE ATROPHY 123 0.0097
683 BLOOD PRESSURE ABNORMAL 193 0.0097
684 MALAISE 4242 0.0097
685 DEMENTIA 270 0.0097
686 TENDON RUPTURE 119 0.0096
687 ACUTE RESPIRATORY DISTRESS SYNDROME 170 0.0096
688 ANOSMIA 139 0.0096
689 LIVER DISORDER 425 0.0096
690 MUSCLE TIGHTNESS 155 0.0096
691 ELECTROCARDIOGRAM QT PROLONGED 343 0.0095
692 SENSORY DISTURBANCE 153 0.0095
693 SPINAL FRACTURE 191 0.0095
694 HYPERSOMNIA 273 0.0095
695 MOOD SWINGS 303 0.0095
696 HYPOACUSIS 409 0.0095
697 SKIN LESION 260 0.0095
698 ASPARTATE AMINOTRANSFERASE INCREASED 503 0.0095
699 VISION BLURRED 1294 0.0094
700 HOSPITALISATION 1445 0.0094
701 MADAROSIS 109 0.0094
702 SPEECH DISORDER 492 0.0094
703 PSYCHOTIC DISORDER 277 0.0094
704 HALLUCINATION, AUDITORY 149 0.0094
705 RASH PRURITIC 508 0.0094
706 POLLAKIURIA 388 0.0093
707 INCONTINENCE 98 0.0093
708 HEAD INJURY 293 0.0092
709 MUSCLE TWITCHING 213 0.0092
710 DECREASED APPETITE 2145 0.0092
711 PRODUCT USE ISSUE 1733 0.0092
712 FATIGUE 7178 0.0092
713 HAIR TEXTURE ABNORMAL 123 0.0092
714 HYPOCALCAEMIA 174 0.0092
715 EYE SWELLING 341 0.0092
716 AGEUSIA 228 0.0091
717 NAUSEA 7225 0.0091
718 PRODUCT DOSE OMISSION ISSUE 2680 0.0091
719 IMMUNE SYSTEM DISORDER 120 0.0091
720 DYSGEUSIA 676 0.0091
721 PSORIATIC ARTHROPATHY 369 0.0091
722 BRADYCARDIA 481 0.0091
723 INTENTIONAL DOSE OMISSION 258 0.0090
724 HYPOKINESIA 131 0.0090
725 INFLAMMATION 465 0.0090
726 MYOCARDIAL INFARCTION 1566 0.0090
727 SKIN ULCER 232 0.0090
728 HEMIPARESIS 152 0.0090
729 BLOOD PRESSURE DECREASED 596 0.0090
730 HERNIA 173 0.0089
731 NEUROPATHY PERIPHERAL 850 0.0089
732 MYALGIA 1519 0.0089
733 DYSARTHRIA 336 0.0089
734 LIVER FUNCTION TEST ABNORMAL 259 0.0089
735 PALLOR 242 0.0089
736 LOCALISED INFECTION 215 0.0089
737 ABDOMINAL DISCOMFORT 1491 0.0089
738 DRUG EXPOSURE DURING PREGNANCY 302 0.0089
739 EYE DISORDER 291 0.0088
740 CARDIAC ARREST 727 0.0088
741 GASTRIC ULCER 167 0.0088
742 EATING DISORDER 187 0.0088
743 LABORATORY TEST ABNORMAL 259 0.0088
744 ECZEMA 459 0.0088
745 DEVICE RELATED INFECTION 135 0.0088
746 MOUTH ULCERATION 184 0.0087
747 DRUG ADMINISTRATION ERROR 267 0.0087
748 BLOOD URINE PRESENT 165 0.0087
749 HERPES ZOSTER 499 0.0087
750 APHASIA 262 0.0087
751 ARTHRALGIA 3597 0.0086
752 DEVICE ISSUE 775 0.0086
753 INCREASED APPETITE 165 0.0086
754 CIRCULATORY COLLAPSE 147 0.0086
755 IRRITABILITY 519 0.0086
756 PRODUCT SUBSTITUTION ISSUE 496 0.0086
757 EMOTIONAL DISTRESS 1042 0.0086
758 ATAXIA 102 0.0086
759 PANCREATITIS ACUTE 193 0.0086
760 ABSCESS 137 0.0086
761 TOOTH DISORDER 190 0.0085
762 FEELING ABNORMAL 2042 0.0085
763 PERIPHERAL COLDNESS 117 0.0085
764 THERAPY NON-RESPONDER 383 0.0085
765 ENCEPHALOPATHY 209 0.0085
766 EMOTIONAL DISORDER 262 0.0085
767 DISEASE RECURRENCE 404 0.0085
768 MATERNAL EXPOSURE DURING PREGNANCY 756 0.0085
769 BONE PAIN 496 0.0085
770 RASH MACULAR 296 0.0085
771 KNEE ARTHROPLASTY 178 0.0084
772 MULTI-ORGAN FAILURE 146 0.0084
773 FEBRILE NEUTROPENIA 560 0.0084
774 RED BLOOD CELL COUNT DECREASED 241 0.0084
775 LOSS OF CONSCIOUSNESS 1079 0.0084
776 RASH 3671 0.0084
777 RESTLESSNESS 308 0.0084
778 INFLUENZA LIKE ILLNESS 691 0.0084
779 DIARRHOEA 5403 0.0084
780 PROCEDURAL PAIN 232 0.0084
781 DISTURBANCE IN ATTENTION 451 0.0084
782 DYSSTASIA 244 0.0083
783 ARRHYTHMIA 394 0.0083
784 VERTIGO 507 0.0083
785 SKIN DISCOLOURATION 382 0.0083
786 PHOTOSENSITIVITY REACTION 137 0.0083
787 DRUG INTERACTION 1316 0.0083
788 PHOTOPHOBIA 156 0.0083
789 MOVEMENT DISORDER 266 0.0083
790 PRURITUS GENERALISED 179 0.0083
791 C-REACTIVE PROTEIN INCREASED 301 0.0083
792 LYMPHOCYTE COUNT DECREASED 146 0.0083
793 DEAFNESS 215 0.0082
794 BASAL CELL CARCINOMA 128 0.0082
795 VISUAL IMPAIRMENT 1012 0.0082
796 CARDIO-RESPIRATORY ARREST 341 0.0081
797 CONVULSION 466 0.0081
798 HEAD DISCOMFORT 144 0.0081
799 FEEDING DISORDER 164 0.0081
800 HYPERTHYROIDISM 117 0.0081
801 FLATULENCE 458 0.0081
802 THIRST 144 0.0081
803 ORAL DISCOMFORT 112 0.0081
804 ORAL HERPES 157 0.0080
805 PRESCRIBED UNDERDOSE 160 0.0080
806 HALLUCINATION, VISUAL 168 0.0079
807 TOOTH EXTRACTION 99 0.0079
808 BEDRIDDEN 104 0.0079
809 PRODUCT USE COMPLAINT 124 0.0079
810 PRODUCT ADMINISTRATION ERROR 159 0.0079
811 SOMNOLENCE 1578 0.0078
812 COLITIS 297 0.0078
813 INTESTINAL OBSTRUCTION 294 0.0078
814 DRY EYE 389 0.0078
815 THINKING ABNORMAL 145 0.0078
816 CHROMATURIA 175 0.0077
817 CARDIAC FAILURE 620 0.0077
818 COLITIS ULCERATIVE 345 0.0077
819 INTENTIONAL DRUG MISUSE 161 0.0077
820 ALANINE AMINOTRANSFERASE INCREASED 471 0.0077
821 PRURITUS 2936 0.0076
822 THERAPY CESSATION 392 0.0076
823 MENTAL IMPAIRMENT 185 0.0076
824 ADVERSE DRUG REACTION 685 0.0076
825 EYE PAIN 429 0.0076
826 COORDINATION ABNORMAL 106 0.0076
827 INTENTIONAL PRODUCT USE ISSUE 661 0.0075
828 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 414 0.0075
829 DRUG DOSE OMISSION 1244 0.0075
830 OFF LABEL USE 6588 0.0075
831 LYMPHOPENIA 105 0.0074
832 HAEMATOCHEZIA 408 0.0074
833 THERAPEUTIC PRODUCT EFFECT DECREASED 331 0.0074
834 ABASIA 182 0.0074
835 DIALYSIS 104 0.0073
836 GINGIVAL BLEEDING 100 0.0073
837 DISORIENTATION 290 0.0073
838 ABDOMINAL PAIN LOWER 185 0.0073
839 HEPATIC FAILURE 220 0.0073
840 SEPTIC SHOCK 317 0.0073
841 UNEVALUABLE EVENT 551 0.0073
842 DRUG LEVEL INCREASED 120 0.0072
843 ERYTHEMA 1489 0.0072
844 PREMATURE DELIVERY 115 0.0072
845 DRUG INEFFECTIVE 9505 0.0072
846 PSORIASIS 938 0.0072
847 OSTEONECROSIS OF JAW 176 0.0071
848 STEVENS-JOHNSON SYNDROME 158 0.0071
849 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1279 0.0071
850 PRODUCT USE IN UNAPPROVED INDICATION 1758 0.0071
851 CEREBROVASCULAR ACCIDENT 1201 0.0071
852 DYSKINESIA 288 0.0071
853 FACE OEDEMA 119 0.0070
854 TREATMENT FAILURE 583 0.0070
855 IMPAIRED WORK ABILITY 150 0.0070
856 LIMB DISCOMFORT 216 0.0070
857 HIP FRACTURE 224 0.0070
858 HEPATOTOXICITY 155 0.0070
859 RASH PAPULAR 156 0.0070
860 FULL BLOOD COUNT DECREASED 140 0.0069
861 RHABDOMYOLYSIS 289 0.0069
862 PARALYSIS 99 0.0069
863 TOXIC EPIDERMAL NECROLYSIS 105 0.0069
864 ERUCTATION 133 0.0069
865 DIABETIC KETOACIDOSIS 165 0.0069
866 SKIN DISORDER 229 0.0069
867 BLOOD CREATINE PHOSPHOKINASE INCREASED 196 0.0068
868 HEPATITIS 174 0.0068
869 SICKLE CELL ANAEMIA WITH CRISIS 107 0.0068
870 ADVERSE EVENT 618 0.0067
871 TOOTH LOSS 138 0.0066
872 FLUSHING 675 0.0066
873 SEIZURE 757 0.0065
874 GENERALISED TONIC-CLONIC SEIZURE 108 0.0065
875 ANAPHYLACTIC SHOCK 167 0.0065
876 VISUAL ACUITY REDUCED 214 0.0064
877 THERAPEUTIC RESPONSE DECREASED 390 0.0064
878 ALOPECIA 1256 0.0064
879 DERMATITIS 134 0.0064
880 PRODUCT PHYSICAL ISSUE 129 0.0064
881 FEMUR FRACTURE 198 0.0064
882 GASTRIC DISORDER 219 0.0064
883 MANIA 104 0.0063
884 DRUG EFFECT DECREASED 340 0.0063
885 NERVOUS SYSTEM DISORDER 197 0.0063
886 DELUSION 98 0.0063
887 BLINDNESS 257 0.0063
888 RENAL IMPAIRMENT 528 0.0063
889 PRODUCT AVAILABILITY ISSUE 142 0.0062
890 OCULAR HYPERAEMIA 295 0.0062
891 ISCHAEMIC STROKE 110 0.0062
892 CARDIOVASCULAR DISORDER 156 0.0061
893 SUICIDE ATTEMPT 370 0.0061
894 PREMATURE BABY 183 0.0061
895 EXPIRED PRODUCT ADMINISTERED 202 0.0061
896 SKIN EXFOLIATION 510 0.0060
897 SHOCK 138 0.0060
898 BLOOD GLUCOSE DECREASED 288 0.0060
899 DRUG-INDUCED LIVER INJURY 188 0.0060
900 INTERSTITIAL LUNG DISEASE 290 0.0060
901 HAEMORRHAGE 625 0.0060
902 FRACTURE 113 0.0060
903 THERAPEUTIC RESPONSE UNEXPECTED 267 0.0059
904 WRONG TECHNIQUE IN DRUG USAGE PROCESS 216 0.0059
905 HOT FLUSH 446 0.0059
906 PANCYTOPENIA 329 0.0059
907 SURGERY 343 0.0058
908 OVERDOSE 1258 0.0058
909 PRODUCT DOSE OMISSION 379 0.0058
910 PLATELET COUNT DECREASED 605 0.0057
911 MUCOSAL INFLAMMATION 146 0.0056
912 RASH MACULO-PAPULAR 123 0.0055
913 TOXICITY TO VARIOUS AGENTS 930 0.0055
914 PLASMA CELL MYELOMA 215 0.0055
915 PROTEINURIA 104 0.0055
916 MUSCULOSKELETAL DISORDER 104 0.0055
917 RASH GENERALISED 141 0.0054
918 LEUKOPENIA 268 0.0054
919 UNDERDOSE 389 0.0053
920 DEVICE BREAKAGE 216 0.0053
921 TARDIVE DYSKINESIA 150 0.0053
922 EYE IRRITATION 306 0.0053
923 INJECTION SITE URTICARIA 130 0.0053
924 THERAPEUTIC RESPONSE SHORTENED 175 0.0053
925 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 177 0.0052
926 SKIN FISSURES 102 0.0052
927 PAIN OF SKIN 139 0.0052
928 MENORRHAGIA 101 0.0051
929 ACCIDENTAL OVERDOSE 188 0.0051
930 OSTEONECROSIS 168 0.0051
931 INCORRECT ROUTE OF DRUG ADMINISTRATION 182 0.0051
932 JAUNDICE 137 0.0051
933 EPILEPSY 155 0.0051
934 COMA 241 0.0051
935 EXPOSURE VIA SKIN CONTACT 131 0.0050
936 DRY SKIN 671 0.0050
937 BONE DENSITY DECREASED 157 0.0050
938 INCORRECT DOSE ADMINISTERED 1137 0.0050
939 BLOOD GLUCOSE INCREASED 937 0.0050
940 EXTRA DOSE ADMINISTERED 201 0.0050
941 NEUTROPHIL COUNT DECREASED 201 0.0049
942 VAGINAL HAEMORRHAGE 209 0.0048
943 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 972 0.0048
944 GLYCOSYLATED HAEMOGLOBIN INCREASED 121 0.0048
945 GAMMA-GLUTAMYLTRANSFERASE INCREASED 105 0.0047
946 PRODUCT PRESCRIBING ISSUE 103 0.0047
947 WHITE BLOOD CELL COUNT DECREASED 510 0.0047
948 NEOPLASM MALIGNANT 314 0.0047
949 DISEASE PROGRESSION 552 0.0047
950 INJECTION SITE SWELLING 357 0.0047
951 FOETAL EXPOSURE DURING PREGNANCY 377 0.0046
952 INCORRECT PRODUCT ADMINISTRATION DURATION 99 0.0046
953 EXTRAPYRAMIDAL DISORDER 113 0.0045
954 DEVICE DISLOCATION 196 0.0045
955 ERECTILE DYSFUNCTION 115 0.0045
956 WITHDRAWAL SYNDROME 188 0.0045
957 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 312 0.0044
958 INJECTION SITE RASH 133 0.0043
959 MULTIPLE SCLEROSIS 206 0.0043
960 ABORTION SPONTANEOUS 170 0.0042
961 INJECTION SITE MASS 152 0.0041
962 DEVICE LEAKAGE 178 0.0041
963 CEREBRAL INFARCTION 100 0.0041
964 INJECTION SITE BRUISING 326 0.0041
965 NEEDLE ISSUE 117 0.0040
966 INJECTION SITE PRURITUS 267 0.0040
967 DEATH 3429 0.0040
968 INJECTION SITE PAIN 1218 0.0040
969 INJECTION SITE REACTION 266 0.0039
970 DERMATITIS ATOPIC 203 0.0038
971 MENSTRUATION IRREGULAR 103 0.0038
972 MULTIPLE SCLEROSIS RELAPSE 263 0.0038
973 DEVICE USE ERROR 133 0.0038
974 CEREBRAL HAEMORRHAGE 134 0.0037
975 NEUTROPENIA 499 0.0037
976 INJECTION SITE ERYTHEMA 446 0.0036
977 DRUG WITHDRAWAL SYNDROME 295 0.0034
978 NO ADVERSE EVENT 599 0.0033
979 DRUG EFFECT INCOMPLETE 120 0.0033
980 INTENTIONAL OVERDOSE 205 0.0032
981 ACNE 240 0.0032
982 DRUG ABUSE 260 0.0031
983 INJECTION SITE HAEMORRHAGE 248 0.0031
984 MALIGNANT NEOPLASM PROGRESSION 294 0.0029
985 SKIN BURNING SENSATION 203 0.0028
986 DRUG DEPENDENCE 440 0.0027
987 ACCIDENTAL EXPOSURE TO PRODUCT 269 0.0026
988 DEVICE DIFFICULT TO USE 171 0.0026
989 SKIN IRRITATION 114 0.0025
990 PRODUCT STORAGE ERROR 210 0.0024
991 BREAST CANCER 210 0.0023
992 PROSTATE CANCER 148 0.0018
993 COMPLETED SUICIDE 110 0.0013